Inflammatory monocyte-derived dendritic cells mediate autoimmunity in murine model of systemic lupus erythematosus

Liu, 2012, Taming lupus-a new understanding of pathogenesis is leading to clinical advances, Nat. Med., 18, 871, 10.1038/nm.2752 Tsokos, 2016, New insights into the immunopathogenesis of systemic lupus erythematosus, Nat. Rev. Rheumatol., 12, 716, 10.1038/nrrheum.2016.186 Bentham, 2015, Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus, Nat. Genet., 47, 1457, 10.1038/ng.3434 Tamura, 2008, The IRF family transcription factors in immunity and oncogenesis, Annu. Rev. Immunol., 26, 535, 10.1146/annurev.immunol.26.021607.090400 Honda, 2005, IRF-7 is the master regulator of type-I interferon-dependent immune responses, Nature, 434, 772, 10.1038/nature03464 Gabriele, 2007, The role of the interferon regulatory factor (IRF) family in dendritic cell development and function, Cytokine Growth Factor Rev., 18, 503, 10.1016/j.cytogfr.2007.06.008 Ouyang, 2011, Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation, Nat. Commun., 2, 314, 10.1038/ncomms1311 Miyagawa, 2012, Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells, Proc. Natl. Acad. Sci. U.S.A., 109, 12123, 10.1073/pnas.1201453109 Miyagawa, 2016, Essential requirement for IFN regulatory factor 7 in autoantibody production but not development of nephritis in murine lupus, J. Immunol., 197, 2167, 10.4049/jimmunol.1502445 Lee Py, 2008, A novel type I IFN-producing cell subset in murine lupus, J. Immunol., 180, 5101, 10.4049/jimmunol.180.7.5101 Bossaller, 2016, TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus, J. Immunol., 197, 1044, 10.4049/jimmunol.1501943 Swaak, 1989, Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively, Ann. Rheum. Dis., 48, 455, 10.1136/ard.48.6.455 Holtschke, 1996, Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene, Cell, 87, 307, 10.1016/S0092-8674(00)81348-3 Nacionales, 2006, Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane), Am. J. Pathol., 168, 1227, 10.2353/ajpath.2006.050125 Reeves, 2009, Induction of autoimmunity by pristane and other naturally occurring hydrocarbons, Trends Immunol., 30, 455, 10.1016/j.it.2009.06.003 Calvani, 2005, Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus, J. Immunol., 175, 4777, 10.4049/jimmunol.175.7.4777 Geissmann, 2008, Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses, Immunol. Cell Biol., 86, 398, 10.1038/icb.2008.19 Kurotaki, 2013, Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation, Blood, 121, 1839, 10.1182/blood-2012-06-437863 Kulkarni, 2007, Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice, J. Am. Soc. Nephrol., 18, 2350, 10.1681/ASN.2006121348 Nacionales, 2007, Deficiency of the type I interferon receptor protects mice from experimental lupus, Arthritis Rheum., 56, 3770, 10.1002/art.23023 Blanco, 2001, Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus, Science, 294, 1540, 10.1126/science.1064890 Zigmond, 2012, Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells, Immunity, 37, 1076, 10.1016/j.immuni.2012.08.026 Serbina, 2003, TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection, Immunity, 19, 59, 10.1016/S1074-7613(03)00171-7 Serbina, 2006, Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2, Nat. Immunol., 7, 311, 10.1038/ni1309 Dunay, 2008, Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii, Immunity, 29, 306, 10.1016/j.immuni.2008.05.019 Lowes, 2005, Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a), Proc. Natl. Acad. Sci. U.S.A., 102, 19057, 10.1073/pnas.0509736102 Ronnblom, 2001, An etiopathogenic role for the type I IFN system in SLE, Trends Immunol., 22, 427, 10.1016/S1471-4906(01)01955-X Ronnblom, 2009, Type I interferon and lupus, Curr. Opin. Rheumatol., 21, 471, 10.1097/BOR.0b013e32832e089e Banchereau, 2006, Type I interferon in systemic lupus erythematosus and other autoimmune diseases, Immunity, 25, 383, 10.1016/j.immuni.2006.08.010 Hooks, 1979, Immune interferon in the circulation of patients with autoimmune disease, N. Engl. J. Med., 301, 5, 10.1056/NEJM197907053010102 Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc. Natl. Acad. Sci. U.S.A., 100, 2610, 10.1073/pnas.0337679100 Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med., 197, 711, 10.1084/jem.20021553 Baccala, 2013, Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus, Proc. Natl. Acad. Sci. U.S.A., 110, 2940, 10.1073/pnas.1222798110 Lovgren, 2004, Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG, Arthritis Rheum., 50, 1861, 10.1002/art.20254 Zhuang, 2015, Animal models of interferon signature positive lupus, Front. Immunol., 6, 291, 10.3389/fimmu.2015.00291 Negishi, 2018, The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family, Cold. Spring. Harb. Perspect. Biol., 10, 10.1101/cshperspect.a028423 Kurotaki, 2016, Transcriptional and epigenetic regulation of innate immune cell development by the transcription factor, interferon regulatory factor-8, J. Interferon Cytokine Res., 36, 433, 10.1089/jir.2015.0138 Tsujimura, 2003, Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells, J. Immunol., 170, 1131, 10.4049/jimmunol.170.3.1131 Aliberti, 2003, Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells, Blood, 101, 305, 10.1182/blood-2002-04-1088 Scheller, 1999, Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein, Blood, 94, 3764, 10.1182/blood.V94.11.3764 Lee, 2006, Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein, J. Exp. Med., 203, 63, 10.1084/jem.20051450 Lee, 2009, Type I interferon modulates monocyte recruitment and maturation in chronic inflammation, Am. J. Pathol., 175, 2023, 10.2353/ajpath.2009.090328 Lee, 2019, High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage, J.C.I. Insight., 4 Luft, 1998, Type I IFNs enhance the terminal differentiation of dendritic cells, J. Immunol., 161, 1947, 10.4049/jimmunol.161.4.1947